Mirror, mirror on the wall, which organs age fastest of them all?
If you could look into a crystal ball and see your medical future, would you? Michael Snyder argues that you should — and that you actually can.
Snyder and his research team have shown that we each have a unique health baseline and that deviations from this baseline precede symptomatic manifestations of diseases and aging. His lab and several companies he has spun off his research are at the frontier of personalized medicine and clinically relevant molecular mechanisms of aging.
![Snyder-wearables-445x529.jpg Snyder-wearables-445x529.jpg](/getattachment/d3a7c80e-70fa-47d8-a59f-fded14dd8f1b/Snyder-wearables-445x529.jpg)
But who is Michael Snyder? The Stanford B. Ascherman professor and chair of genetics and director of genomics and personalized medicine at Stanford University School of Medicine describes himself as a guinea pig for many of his research ideas. He says he wears at least eight devices designed to measure his personal health baseline continuously (including heart rate, skin temperature, blood glucose and oxygen levels). He loves to tell the story of how he got infected with Lyme disease while helping his brother build fences in rural Massachusetts and detected the infection based on his wearables two weeks later.
A decade ago, Snyder persuaded his then 84-year-old mother to participate in (and be a co-author on) a research study about himself that he published in Cell. Around the same time, he recruited a cohort of over 100 people that his team studied for up to 10 years, which led to the discovery of several cases of early-stage cancers, heart defects and other conditions — so he is also a lifesaver. Overall, he could be described as a curious visionary, pushing the boundaries of medicine into a new orbit.
In a recent paper published in the journal Nature Medicine, Snyder's team describes how the aging process can be detected on a molecular level in individuals over a span of two years. Different people age in different ways, which the researchers refer to as aging types, or ageotypes.
Some ageotypes involve the cardiovascular system, the kidney and liver, and the metabolic and immune systems. Individuals can display one, some or all of the different aging types — Snyder himself is a metabolic, kidney and liver ageotype, and he postulates that there are many more types that his team is not able to detect yet due to insufficient data.
Learn more
Read "Mom and iPop," ASBMB Today's 2012 cover story about Michael Snyder's research study with his mother.
This methodology and conceptual framework can be used to monitor anti-aging strategies on an individual level and potentially intervene. For example, a person with an immune ageotype might eat more garlic or take turmeric as a supplement. It's still in the research stage, but Snyder is working on a commercial test idea.
For Snyder, precision health starts with measuring an individual health baseline. His research and personal experience have shown that a change in heart rate is one of the earliest indicators of many diseases and that a commercial device such as a FitBit can pick up this deviation from the baseline. This also applies to COVID-19, where he and his team were able to detect an elevation in resting heart rate in 81% of cases a median of four days prior to symptoms and in some cases as much as 10 days. "Our group has recently developed this into an early alarming system for COVID-19 and other respiratory illnesses," Snyder said, "and we hope to enroll as many as 10 million participants (in a study)."
Snyder is also a big proponent of continuous glucose monitoring. Participants in his longitudinal study were screened for prediabetes and diabetes, and several of them converted from healthy to prediabetic or diabetic during the study. However, the researchers also saw that individuals determined to be healthy by clinical tests such as fasting glucose levels and A1C levels could display large spikes in blood glucose levels after meals, indicating that their bodies repeatedly were unable to deal efficiently with the glucose from the absorbed meals, further supporting the idea that existing clinical tests are insufficient to capture disease in its earliest forms. Unfortunately, continuous glucose monitoring is expensive.
Snyder points out that "medical economic modeling supports the idea that in many cases it is cheaper to screen for disease to capture and treat it in its earliest stages," but he admits that medical insurance companies have not yet embraced this concept fully.
![Aging-image-1000x672.jpg Aging-image-1000x672.jpg](/getattachment/c0cf65da-6801-4acd-97ec-8894b008003a/Aging-image-1000x672.jpg)
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
![The quest to treat and cure xerostomia](/getmedia/09045019-5c58-4434-9eb0-d6be609842cb/Xerostomia-thumb.jpg?width=480&height=270&ext=.jpg)
The quest to treat and cure xerostomia
Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.
![There's more to blue cheese than just the stench](/getmedia/65d1751a-27b4-405b-9210-8cde34249ef5/More-to-blue-cheese-480x270.jpg?width=480&height=270&ext=.jpg)
There's more to blue cheese than just the stench
Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.
![Engineering cells to broadcast their behavior can help scientists study their inner workings](/getmedia/a5c8da38-1a39-4183-be72-85d5cbff8a29/Engeneering-cells-to-broadcast-480x270.jpg?width=480&height=270&ext=.jpg)
Engineering cells to broadcast their behavior can help scientists study their inner workings
Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.
![From the journals: JBC](/getmedia/a3620094-c80e-41b9-91ab-22037b087112/FTJ-JBC-07-19-24-480x270.jpg?width=480&height=270&ext=.jpg)
From the journals: JBC
Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.
![Seeking the sweet spot to beat a pig parasite](/getmedia/30869767-881b-438b-9f19-531ef9eee79e/Pig-parasite-480x270.jpg?width=480&height=270&ext=.jpg)
Seeking the sweet spot to beat a pig parasite
Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.
![Radioactive drugs strike cancer with precision](/getmedia/f3a6418b-340a-43cc-b53f-30916dbbd8f4/Radioactive-drugs-strike-cancer-480x270.jpg?width=480&height=270&ext=.jpg)
Radioactive drugs strike cancer with precision
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.